Effect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs

Beneficial effects of <i>n</i>-3 fatty acids on metabolic biomarkers in patients with type 2 diabetes (T2DM) has been reported. The objectives of this current research were to investigate the effects of <i>n</i>-3 supplementation on metabolic factors, weight, and body mass in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leila Khalili, Roxana Valdes-Ramos, Laurence S. Harbige
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/32902911b1b14aa4b5d663b1fd87f7c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:32902911b1b14aa4b5d663b1fd87f7c2
record_format dspace
spelling oai:doaj.org-article:32902911b1b14aa4b5d663b1fd87f7c22021-11-25T18:20:35ZEffect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs10.3390/metabo111107422218-1989https://doaj.org/article/32902911b1b14aa4b5d663b1fd87f7c22021-10-01T00:00:00Zhttps://www.mdpi.com/2218-1989/11/11/742https://doaj.org/toc/2218-1989Beneficial effects of <i>n</i>-3 fatty acids on metabolic biomarkers in patients with type 2 diabetes (T2DM) has been reported. The objectives of this current research were to investigate the effects of <i>n</i>-3 supplementation on metabolic factors, weight, and body mass index (BMI) in patients with type 2 diabetes mellitus (T2DM), using a meta-analysis of randomized, controlled trials (RCTs). Online databases PubMed, Embase, Web of Science, and Science Direct were searched until 2021 to identify eligible articles. Thirty trials were included. The results showed that <i>n</i>-3 consumption can significantly reduce glycemic factors including fasting blood sugar (FBS) (−0.36 (−0.71 to −0.01)), glycated hemoglobulin (HbA1c) (−0.74 (−1.13 to −0.35)), and homeostatic model assessment of insulin resistance (HOMA.IR) (−0.58 (−1.13 to −0.03)). Furthermore, significant improvement in lipid profile including triglycerides (TG) (−0.27 (−0.37 to −0.18)), total cholesterol (−0.60 (−0.88 to −0.32)), low density lipoprotein (LDL) (−0.54 (−0.85 to −0.23)), and high-density lipoprotein (HDL) (0.60 (0.23 to 0.96)) levels were found in the present meta-analysis. The reduction in the inflammatory marker’s tumor necrosis factor-alpha (TNF-α) (−0.13 (−0.75 to 0.48)) and c-reactive protein (CRP) (−0.72 (−1.70 to 0.27)), as well as weight (−0.09 (−0.24 to 0.07)) and BMI (−0.13 (−0.29 to 0.02)) were not statistically significant. Furthermore, the findings revealed that the optimal dose and duration of <i>n</i>-3 consumption for patients with T2DM is 1000–2000 mg/d for more than 8 weeks. The present meta-analysis and review reveals that <i>n</i>-3 supplementation can improve glycemic factors and lipid profile in patients with T2DM. Furthermore, <i>n</i>-3 supplementation may provide beneficial effects on inflammatory markers and body weight if used at the appropriate dose and duration.Leila KhaliliRoxana Valdes-RamosLaurence S. HarbigeMDPI AGarticlemeta-analysis<i>n</i>-3polyunsaturated fatty acids PUFAT2DMdiabetesrandomized controlled trials RCTsMicrobiologyQR1-502ENMetabolites, Vol 11, Iss 742, p 742 (2021)
institution DOAJ
collection DOAJ
language EN
topic meta-analysis
<i>n</i>-3
polyunsaturated fatty acids PUFA
T2DM
diabetes
randomized controlled trials RCTs
Microbiology
QR1-502
spellingShingle meta-analysis
<i>n</i>-3
polyunsaturated fatty acids PUFA
T2DM
diabetes
randomized controlled trials RCTs
Microbiology
QR1-502
Leila Khalili
Roxana Valdes-Ramos
Laurence S. Harbige
Effect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs
description Beneficial effects of <i>n</i>-3 fatty acids on metabolic biomarkers in patients with type 2 diabetes (T2DM) has been reported. The objectives of this current research were to investigate the effects of <i>n</i>-3 supplementation on metabolic factors, weight, and body mass index (BMI) in patients with type 2 diabetes mellitus (T2DM), using a meta-analysis of randomized, controlled trials (RCTs). Online databases PubMed, Embase, Web of Science, and Science Direct were searched until 2021 to identify eligible articles. Thirty trials were included. The results showed that <i>n</i>-3 consumption can significantly reduce glycemic factors including fasting blood sugar (FBS) (−0.36 (−0.71 to −0.01)), glycated hemoglobulin (HbA1c) (−0.74 (−1.13 to −0.35)), and homeostatic model assessment of insulin resistance (HOMA.IR) (−0.58 (−1.13 to −0.03)). Furthermore, significant improvement in lipid profile including triglycerides (TG) (−0.27 (−0.37 to −0.18)), total cholesterol (−0.60 (−0.88 to −0.32)), low density lipoprotein (LDL) (−0.54 (−0.85 to −0.23)), and high-density lipoprotein (HDL) (0.60 (0.23 to 0.96)) levels were found in the present meta-analysis. The reduction in the inflammatory marker’s tumor necrosis factor-alpha (TNF-α) (−0.13 (−0.75 to 0.48)) and c-reactive protein (CRP) (−0.72 (−1.70 to 0.27)), as well as weight (−0.09 (−0.24 to 0.07)) and BMI (−0.13 (−0.29 to 0.02)) were not statistically significant. Furthermore, the findings revealed that the optimal dose and duration of <i>n</i>-3 consumption for patients with T2DM is 1000–2000 mg/d for more than 8 weeks. The present meta-analysis and review reveals that <i>n</i>-3 supplementation can improve glycemic factors and lipid profile in patients with T2DM. Furthermore, <i>n</i>-3 supplementation may provide beneficial effects on inflammatory markers and body weight if used at the appropriate dose and duration.
format article
author Leila Khalili
Roxana Valdes-Ramos
Laurence S. Harbige
author_facet Leila Khalili
Roxana Valdes-Ramos
Laurence S. Harbige
author_sort Leila Khalili
title Effect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs
title_short Effect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs
title_full Effect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs
title_fullStr Effect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs
title_full_unstemmed Effect of <i>n</i>-3 (Omega-3) Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers and Body Weight in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of RCTs
title_sort effect of <i>n</i>-3 (omega-3) polyunsaturated fatty acid supplementation on metabolic and inflammatory biomarkers and body weight in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of rcts
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/32902911b1b14aa4b5d663b1fd87f7c2
work_keys_str_mv AT leilakhalili effectofini3omega3polyunsaturatedfattyacidsupplementationonmetabolicandinflammatorybiomarkersandbodyweightinpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysisofrcts
AT roxanavaldesramos effectofini3omega3polyunsaturatedfattyacidsupplementationonmetabolicandinflammatorybiomarkersandbodyweightinpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysisofrcts
AT laurencesharbige effectofini3omega3polyunsaturatedfattyacidsupplementationonmetabolicandinflammatorybiomarkersandbodyweightinpatientswithtype2diabetesmellitusasystematicreviewandmetaanalysisofrcts
_version_ 1718411310586134528